Evidence map›Paper›PMID 40148934›Full record

ArticleVirology journal2025

Anellovirus abundance as an indicator for viral metagenomic classifier utility in plasma samples.

Gabriel Montenegro de Campos, Luan Gaspar Clemente, Alex Ranieri Jerônimo Lima, Eleonora Cella, Vagner Fonseca, João Paulo Bianchi Ximenez, Milton Yutaka Nishiyama, Enéas de Carvalho, Sandra Coccuzzo Sampaio, Marta Giovanetti and 2 more

Abstract readEvaluation Study
In one paragraph

Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gabriel Montenegro de CamposPrograma de Pós-graduação em Oncologia Clínica, Células-Tronco e Terapia Celular, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Prêto, Brazil.
Luan Gaspar ClementeEscola Superior de Agricultura Luiz de Queiroz, Departamento de Zootecnia, Universidade de São Paulo, Piracicaba, Brazil.
Alex Ranieri Jerônimo LimaCentro de Vigilância Viral e Avaliação Sorológica- CeVIVas, Instituto Butantan, São Paulo, Brazil.
Eleonora CellaBurnett School of Medical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
Vagner FonsecaDepartamento de Ciências Exatas e Terra, Universidade Estadual da Bahia, Salvador, Brazil.
João Paulo Bianchi XimenezDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Prêto, Brazil.
Milton Yutaka NishiyamaLaboratório de Toxinologia Aplicada, Instituto Butantan, São Paulo, Brazil.
Enéas de CarvalhoLaboratório de Bacteriologia, Instituto Butantan, São Paulo, Brazil.
Sandra Coccuzzo SampaioCentro de Vigilância Viral e Avaliação Sorológica- CeVIVas, Instituto Butantan, São Paulo, Brazil.
Marta GiovanettiDepartment of Science and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy.
Maria Carolina EliasCentro de Vigilância Viral e Avaliação Sorológica- CeVIVas, Instituto Butantan, São Paulo, Brazil.
Svetoslav Nanev SlavovCentro de Vigilância Viral e Avaliação Sorológica- CeVIVas, Instituto Butantan, São Paulo, Brazil. svetoslav.slavov@fundacaobutantan.org.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 403075/2023-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/23205-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/11944-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/00910-6
6 · The paper itself

Abstract

backgroundViral metagenomics has expanded significantly in recent years due to advancements in next-generation sequencing, establishing it as the leading method for identifying emerging viruses. A crucial step in metagenomics is taxonomic classification, where sequence data is assigned to specific taxa, thereby enabling the characterization of species composition within a sample. Various taxonomic classifiers have been developed in recent years, each employing distinct classification approaches that produce varying results and abundance profiles, even when analyzing the same sample.

methodsIn this study, we propose using the identification of Torque Teno Viruses (TTVs), from the Anelloviridae family, as indicators to evaluate the performance of four short-read-based metagenomic classifiers: Kraken2, Kaiju, CLARK and DIAMOND, when evaluating human plasma samples.

resultsOur results show that each classifier assigns TTV species at different abundance levels, potentially influencing the interpretation of diversity within samples. Specifically, nucleotide-based classifiers tend to detect a broader range of TTV species, indicating higher sensitivity, while amino acid-based classifiers like DIAMOND and CLARK display lower abundance indices. Interestingly, despite employing different algorithms and data types (protein-based vs. nucleotide-based), Kaiju and Kraken2 performed similarly.

conclusionOur study underscores the critical impact of classifier selection on diversity indices in metagenomic analyses. Kaiju effectively assigned a wide variety of TTV species, demonstrating it did not require a high volume of reads to capture diversity. Nucleotide-based classifiers like CLARK and Kraken2 showed superior sensitivity, which is valuable for detecting emerging or rare viruses. At the same time, protein-based approaches such as DIAMOND and Kaiju proved robust for identifying known species with low variability.

Indexed as

AnelloviridaeMetagenomicsPlasmaTorque teno virusHigh-Throughput Nucleotide SequencingHumansAbundanceMetagenomicsTaxonomic classifiersTorque teno virusesTTV

Identifiers

PMID40148934
PMCPMC11951539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.